ACCS vs RARE · rev $10.9M vs rev $350.0M
ACCESS Newswire Inc. (ACCS) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
ACCESS Newswire Inc. (ACCS) is a advertising agencies company listed on AMEX.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ACCS revenue for 2026-06-30 was $10.9M. Net income was -$1.1M. ACCS currently screens at market cap $24.1M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ACCS currently screens at market cap $24.1M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ACCS and RARE stock pages for the full models.
Not investment advice.